Eli Lilly and Company (LLY) Profit Margin
Eli Lilly and Company (LLY) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 12.90% |
| 2017-12-31 | -0.89% |
| 2018-12-31 | 15.04% |
| 2019-12-31 | 37.27% |
| 2020-12-31 | 25.24% |
| 2021-12-31 | 19.71% |
| 2022-12-31 | 21.88% |
| 2023-12-31 | 15.36% |
| 2024-12-31 | 23.51% |
| 2025-12-31 | 31.67% |
How LLY compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| EXEL | Exelixis Inc. | 33.73% |
| VRTX | Vertex Pharmaceuticals Incorporated | 32.94% |
| REGN | Regeneron Pharmaceuticals Inc. | 31.41% |
| GILD | Gilead Sciences Inc. | 28.90% |
| ADMA | ADMA Biologics Inc | 28.80% |
These are five companies in the same sector as LLY with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Eli Lilly and Company Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("LLY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LLY | $1231.94 | +3.90% | 3.01M |
| 3 | ||||
| 4 | ||||
| 5 |